Osamu Maenishi

Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody Cetuximab

Kimio Yonesaka, Kreshnik Zejnullahu, Isamu Okamoto et al. · Science Translational Medicine · 2011 · 670 citations

Medicine, Oncology, Pharmacology +17

DS‐8201a, a new HER2‐targeting antibody–drug conjugate incorporating a novel DNA topoisomerase I inhibitor, overcomes HER2‐positive gastric cancer T‐DM1 resistance

Naoki Takegawa, Yoshikane Nonagase, Kimio Yonesaka et al. · International Journal of Cancer · 2017 · 195 citations · Full text

Medicine, Oncology, Pharmacology +17

B7-H3 Negatively Modulates CTL-Mediated Cancer Immunity

Kimio Yonesaka, Koji Haratani, Shiki Takamura et al. · Clinical Cancer Research · 2018 · 169 citations

Medicine, Immunology, Oncology +17

Identification and characterization of IgG4-associated autoimmune hepatitis

Hobyung Chung, Tomohiro Watanabe, Masatoshi Kudo et al. · Liver International · 2009 · 109 citations

Medicine, Immunology, Pathology +14

Multimaterial Decomposition Algorithm for the Quantification of Liver Fat Content by Using Fast-Kilovolt-Peak Switching Dual-Energy CT: Clinical Evaluation

Tomoko Hyodo, Norihisa Yada, Masatoshi Hori et al. · Radiology · 2017 · 100 citations

Medicine, Nuclear Medicine, Radiology +17